These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33287777)

  • 1. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease.
    Tashiro H; Kurihara Y; Takahashi K; Sadamatsu H; Haraguchi T; Tajiri R; Takamori A; Kimura S; Sueoka-Aragane N
    BMC Pulm Med; 2020 Dec; 20(1):318. PubMed ID: 33287777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
    Capozzolo A; Carratù P; Dragonieri S; Falcone VA; Quaranta VN; Liotino V; D'Alba G; Castellana G; Resta O
    Respir Care; 2017 May; 62(5):572-578. PubMed ID: 28270543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
    Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.
    Criner GJ; Celli BR; Singh D; Agusti A; Papi A; Jison M; Makulova N; Shih VH; Brooks L; Barker P; Martin UJ; Newbold P
    Lancet Respir Med; 2020 Feb; 8(2):158-170. PubMed ID: 31575508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.
    Rhee CK; Choi JY; Park YB; Yoo KH
    J Korean Med Sci; 2024 May; 39(19):e164. PubMed ID: 38769923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CODEXS: A New Multidimensional Index to Better Predict Frequent COPD Exacerbators with Inclusion of Depression Score.
    Deng D; Zhou A; Chen P; Shuang Q
    Int J Chron Obstruct Pulmon Dis; 2020; 15():249-259. PubMed ID: 32099350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
    Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
    Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COPD Exacerbation Frequency on Costs for a Managed Care Population.
    Dalal AA; Patel J; D'Souza A; Farrelly E; Nagar S; Shah M
    J Manag Care Spec Pharm; 2015 Jul; 21(7):575-83. PubMed ID: 26108382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.
    Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of frequency of exacerbations with the BODE index in COPD patients.
    Hodgev VA; Kostianev SS; Marinov BA
    Folia Med (Plovdiv); 2006; 48(2):18-22. PubMed ID: 17408072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients.
    Song Q; Zhao YY; Zeng YQ; Liu C; Cheng W; Deng MH; Li X; Ma LB; Chen Y; Cai S; Chen P
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1401-1412. PubMed ID: 34040367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.